Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes-Reference-Cited by-同舟云学术

Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes

Published:2005-12-10 Issue:1 Volume:49 Page:49-55
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Guzder R. N.,Gatling W.,Mullee M. A.,Byrne C. D.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00125-005-0063-9.pdf

Reference24 articles.

1. World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. WHO, Geneva

2. Adult Treatment Panel III (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486–2497

3. Balkau B, Charles MA (1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16:442–443

4. McNeill AM, Rosamond WD, Girman CJ et al (2005) The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28:385–390

5. Girman CJ, Rhodes T, Mercuri M et al (2004) The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 93:136–141

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction;Metabolism and Target Organ Damage;2024-08-28

2. The MAFLD‐MASLD debate: Does cardiovascular risk prediction define the winner?;Liver International;2024-06-17

3. Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes;Diabetes Care;2024-03-18

4. MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?;Metabolism and Target Organ Damage;2024-02-27

5. Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis;Communications Medicine;2024-01-22